A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...
On June 7th, Era Biology hosted a live webinar for Latin America. The webinar focuses on antimicrobial resistance problem. Since 2005, the antibiotic resistance rate of bacteria has been increasing...
Era Biology at ECCMID 2023, Denmark
Era Biology, a leader and pioneer of invasive fungal disease (IFD) diagnostics field, has exhibited at the European Congress of Clinical Microbiology and Infecti...
On June 28, the “National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crab Marine Biomedicine Industrial Park” invested and c...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...